2018 American Transplant Congress Archives - Page 105 of 211

Is Kidney Transplantation Safe in Patients over 71 Years Old?

G. Andani, P. Tulissi, M. Gropuzzo, S. Crestani, C. Vallone, U. Baccarani, D. Montanaro, A. Risaliti.
Is Percent Exception at Transplant a Driver of MELD Inflation?

D. Schladt,¹ J. Snyder,¹ A. Israni,¹ W. Kim,² J. Lake.³
Is Renal Function after Heart Transplantation an Issue for Patients with Cardiac Amyloidosis?

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Is the NETos Increased in Acute Antibody Mediated Rejection?

R. Villca-Gonzales,¹ J. Torres-Ruiz,² D. Gomez-Martin,² J. Alberu,³ L. Morales-Buenrostro.¹
Isavuconazole – The Real-World Use Experience

H. Hassouna, V. Athans, K. Brizendine.
Ischemia Reperfusion Injury & Risk for Antibody Mediated Rejection (ABMR) in HLA Sensitized Patients Treated with C1 Esterase Inhibitor (C1INH)

A. Vo,¹ O. Aubert,² J. Choi,¹ N. Ammerman,¹ H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ S. Jordan.¹
Ischemia Reperfusion Injury in Liver Transplantation is Associated with Acute Kidney Injury: Role of Inflammatory Mediators

P. Mihaylov,^1,2 P. Li,¹ J. Skill,¹ L. Timsina,¹ J. Fridell,¹ B. Ekser,¹ R. Mangus,¹ C. Kubal.¹
Ischemia Reperfusion Injury Significantly Differs between Lung vs. Heart Transplantation with Respect to Lead Cytokines and Correlation to Clinical Outcome

B. Wiegmann,¹ N. Ledwoch,² J. ISke,² C. Neudörfl,² I. Tudorache,¹ C. Kühn,¹ T. Kaufeld,¹ F. Ius,¹ S. Rojas,¹ M. Avsar,¹ A. Haverich,¹ G. Warnwcke,¹ C. Falk.¹
Ischemia-Free Liver Transplantation for Fatty Liver Grafts in Human

W. Ju, S. Huang, Z. Guo, G. Chen, X. He.
Ischemia-Free Liver Transplantation in Pigs: Ischemia Reperfusion Injury is Avoidable?

Z. Guo, X. He, Y. Tang, F. Ji, Z. Zhang, Q. Zhao, S. Huang, Z. Zhu, W. Ju, G. Chen.